CIBC World Market’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,187
Closed -$60K 1306
2024
Q2
$60K Sell
14,187
-625
-4% -$2.53K ﹤0.01% 1232
2024
Q1
$75K Sell
14,812
-485
-3% -$2.73K ﹤0.01% 1258
2023
Q4
$142K Sell
15,297
-496
-3% -$3.42K ﹤0.01% 1189
2023
Q3
$103K Sell
15,793
-62
-0.4% -$493 ﹤0.01% 1181
2023
Q2
$129K Sell
15,855
-183
-1% -$1.57K ﹤0.01% 1157
2023
Q1
$137K Sell
16,038
-145
-0.9% -$1.45K ﹤0.01% 1175
2022
Q4
$150K Sell
16,183
-136
-0.8% -$1.45K ﹤0.01% 1183
2022
Q3
$168K Sell
16,319
-154
-0.9% -$1.63K ﹤0.01% 1145
2022
Q2
$165K Buy
16,473
+123
+0.8% +$1.17K ﹤0.01% 1172
2022
Q1
$201K Buy
16,350
+96
+0.6% +$1.18K ﹤0.01% 1211
2021
Q4
$282K Buy
16,254
+517
+3% +$9.82K ﹤0.01% 1147
2021
Q3
$282K Buy
+15,737
New +$313K ﹤0.01% 1145

Other funds holding AVXL